NDC 66993-482

Abacavir and Lamivudine

Abacavir Sulfate And Lamivudine

Abacavir and Lamivudine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Prasco Laboratories. The primary component is Abacavir Sulfate; Lamivudine.

Product ID66993-482_9d19ef2d-cd3c-4b46-b28e-22c236c7337a
NDC66993-482
Product TypeHuman Prescription Drug
Proprietary NameAbacavir and Lamivudine
Generic NameAbacavir Sulfate And Lamivudine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2016-09-29
Marketing End Date2020-12-31
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA021652
Labeler NamePrasco Laboratories
Substance NameABACAVIR SULFATE; LAMIVUDINE
Active Ingredient Strength600 mg/1; mg/1
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN

Packaging

NDC 66993-482-30

30 TABLET, FILM COATED in 1 BOTTLE (66993-482-30)
Marketing Start Date2016-09-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66993-482-30 [66993048230]

Abacavir and Lamivudine TABLET, FILM COATED
Marketing CategoryNDA authorized generic
Application NumberNDA021652
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-09-29
Marketing End Date2020-12-31

Drug Details

Active Ingredients

IngredientStrength
ABACAVIR SULFATE600 mg/1

OpenFDA Data

SPL SET ID:133490fc-26eb-4c92-a21d-52be4c226b74
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 602393

    • Pharmacological Class

    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    Medicade Reported Pricing

    66993048230 ABACAVIR-LAMIVUDINE 600-300 MG

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Abacavir and Lamivudine" or generic name "Abacavir Sulfate And Lamivudine"

    NDCBrand NameGeneric Name
    0093-5382Abacavir and LamivudineAbacavir and Lamivudine
    35573-402Abacavir and LamivudineAbacavir and Lamivudine
    35573-430Abacavir and LamivudineAbacavir and Lamivudine
    42291-115Abacavir and LamivudineAbacavir and Lamivudine
    42385-962Abacavir and LamivudineAbacavir and Lamivudine
    65862-335Abacavir and LamivudineAbacavir and Lamivudine
    65862-900Abacavir and LamivudineAbacavir and Lamivudine
    66993-482Abacavir and Lamivudineabacavir sulfate and lamivudine
    68180-288Abacavir and LamivudineAbacavir and Lamivudine
    69097-362Abacavir and LamivudineAbacavir and lamivudine
    70518-0715Abacavir and LamivudineAbacavir and Lamivudine
    70771-1053Abacavir and lamivudineAbacavir and lamivudine
    70710-1049Abacavir and lamivudineAbacavir and lamivudine
    49349-701EpzicomAbacavir Sulfate and Lamivudine
    49702-206EPZICOMabacavir sulfate and lamivudine
    50090-0874EPZICOMabacavir sulfate and lamivudine
    53808-0767EPZICOMabacavir sulfate and lamivudine
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.